These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18549684)

  • 61. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Variability of serum gonadotropin and dehydroepiandrosterone sulfate concentrations in women with polycystic ovary syndrome.
    Oei ML; Kazer RR
    J Reprod Med; 1992 Dec; 37(12):974-8. PubMed ID: 1287208
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
    Uncu G; Sözer MC; Develioğlu O; Cengiz C
    Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).
    Lin KC; Lee JN
    Kaohsiung J Med Sci; 1998 Feb; 14(2):61-7. PubMed ID: 9542361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
    Skiba MA; Islam RM; Bell RJ; Davis SR
    Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Insulin gene polymorphism in women with polycystic ovary syndrome.
    Ferk P; Perme MP; Gersak K
    J Int Med Res; 2008; 36(6):1180-7. PubMed ID: 19094425
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?
    Stener-Victorin E; Holm G; Labrie F; Nilsson L; Janson PO; Ohlsson C
    J Clin Endocrinol Metab; 2010 Feb; 95(2):810-9. PubMed ID: 20016048
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E; Fruzzetti F; Lobo RA
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
    Xu XH; Tan YC; Shi YH; Wang B; Ju XQ; Zheng QM; Hao CF; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2604-6. PubMed ID: 20137675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of bromocriptine on LH pulsatility in the polycystic ovary syndrome.
    Chapman AJ; Wilson MD; Obhrai M; Sawers RS; Lynch SS; Royston JP; Clayton RN
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):571-80. PubMed ID: 3450455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
    Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome.
    Rajkhowa M; Talbot JA; Jones PW; Pettersson K; Haavisto AM; Huhtaniemi I; Clayton RN
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):297-303. PubMed ID: 7586598
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome.
    Elting MW; Korsen TJ; Schoemaker J
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.